Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)

Nippon rinsho. Japanese journal of clinical medicine

Volumn 60, Issue 10, 2002, Pages 1992-1998

  Shibasaki, Yasunobu ^a   Nishiue, Takashi ^a   Masaki, Hiroya ^a   Matsubara, Hiroaki ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ARTICLE; CARDIOMYOPATHY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; FIBROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHIES; ENALAPRIL; FEMALE; FIBROSIS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; LOSARTAN; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, ANGIOTENSIN; RENAL DIALYSIS;

EID: 0036776950     PISSN: 00471852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)